We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

This study is currently recruiting participants.
Verified October 2017 by Horng Chen, Mayo Clinic
Sponsor:
ClinicalTrials.gov Identifier:
NCT01678794
First Posted: September 5, 2012
Last Update Posted: October 4, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Horng Chen, Mayo Clinic
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 30, 2018
  Estimated Primary Completion Date: January 31, 2018 (Final data collection date for primary outcome measure)